Shortwin LS Oral Suspension
By Shortwin LS
Rx
100ml Oral Suspension in a Bottle

Composition
Ambroxol(30mg/5ml) + Levosalbutamol(1mg/5ml) + Guaifenesin(50mg/5ml)

Manufacturer - Orsis Pharmaceuticals
scf 6, housing board phase 1, sai road baddi solan h p

Expires on or after
September, 2025

liver
Shortwin LS Oral Suspension should be used cautiously in individuals with liver disease. It may be necessary to adjust the dosage of Shortwin LS Oral Suspension under these conditions. It is advisable to consult your healthcare provider before using this product, as there is limited information on its use in patients with liver issues.

kidney
Shortwin LS Oral Suspension should be used with caution in patients with kidney disease. Dose adjustment may be necessary, and limited information is available. Please consult your doctor.

alcohol
It is unclear if it is safe to drink alcohol while using Shortwin LS Oral Suspension. Please seek advice from your doctor.

driving
Shortwin LS Oral Suspension may cause drowsiness, blurred vision, or dizziness. Avoid driving if experiencing these effects.

pregnancy
Shortwin LS Oral Suspension may be unsafe during pregnancy. Limited human studies and animal studies show potential harm to the baby. Consult your doctor for evaluation of benefits and risks before use.

breastfeeding
"Information on using Shortwin LS Oral Suspension while breastfeeding is not available. It is recommended to consult your doctor."
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹49
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025